WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 597855
Description: Zofenoprilat arginine is an antihypertensive agent.
MedKoo Cat#: 597855
Name: Zofenoprilat arginine
Chemical Formula: C21H33N5O5S2
Molecular Weight: 499.64
Elemental Analysis: C, 50.48; H, 6.66; N, 14.02; O, 16.01; S, 12.83
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Zofenoprilat arginine; SQ 26703; SQ-26703; SQ26703; SQ 26,703; SQ-26,703; SQ26,703;
IUPAC/Chemical Name: (2S,4S)-1-((S)-3-mercapto-2-methylpropanoyl)-4-(phenylthio)pyrrolidine-2-carboxylic acid compound with L-arginine (1:1)
InChi Key: OSKWTWSFSUAPKP-KQUFBQNASA-N
InChi Code: InChI=1S/C15H19NO3S2.C6H14N4O2/c1-10(9-20)14(17)16-8-12(7-13(16)15(18)19)21-11-5-3-2-4-6-11;7-4(5(11)12)2-1-3-10-6(8)9/h2-6,10,12-13,20H,7-9H2,1H3,(H,18,19);4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t10-,12+,13+;4-/m10/s1
SMILES Code: C[C@@H](C(N1C[C@@H](Sc2ccccc2)C[C@H]1C(O)=O)=O)CS.N[C@H](C(O)=O)CCCNC(N)=N
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
The following data is based on the product molecular weight 499.64 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|
1: van Gilst WH, de Graeff PA, de Leeuw MJ, Scholtens E, Wesseling H. Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogenous nitrovasodilators. J Cardiovasc Pharmacol. 1991 Sep;18(3):429-36. PubMed PMID: 1720843.